Revenue Growth Benchmark

In 2022, global sales reached approximately $1.5 trillion. Our platform highlights over 500 innovator drugs, contributing to a market value of nearly $650 billion.

The leading therapy areas for innovative drugs were oncology, anti-virals, and immunology, which together made up 60% of worldwide sales in 2022. Anti-virals saw particularly significant sales growth, with a CAGR of 29%, largely driven by the increased demand for COVID-19 treatments. By contrast, oncology and immunology grew at CAGRs of 12% and 10%, respectively.

For a deeper understanding, you can explore extensive five-year sales data from leading global pharmaceutical companies, meticulously organized by therapy areas.